Hutchin Hill Capital’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-29,900
| Closed | -$607K | – | 833 |
|
|
2017
Q3 | $607K | Buy |
+29,900
| New | +$607K | 0.02% | 474 |
|
|
2017
Q1 | – | Sell |
-42,700
| Closed | -$566K | – | 1110 |
|
|
2016
Q4 | $566K | Buy |
+42,700
| New | +$566K | 0.02% | 541 |
|
|
2016
Q3 | – | Sell |
-43,300
| Closed | -$1.25M | – | 753 |
|
|
2016
Q2 | $1.25M | Buy |
43,300
+21,400
| +98% | +$617K | 0.04% | 235 |
|
|
2016
Q1 | $701K | Buy |
+21,900
| New | +$701K | 0.02% | 457 |
|
|
2015
Q1 | – | Sell |
-16,000
| Closed | -$507K | – | 849 |
|
|
2014
Q4 | $507K | Buy |
+16,000
| New | +$507K | 0.02% | 436 |
|
|
2013
Q4 | – | Sell |
-29,400
| Closed | -$602K | – | 687 |
|
|
2013
Q3 | $602K | Sell |
29,400
-8,300
| -22% | -$170K | 0.05% | 293 |
|
|
2013
Q2 | $752K | Buy |
+37,700
| New | +$752K | 0.08% | 210 |
|